Real-Time Monitoring of Antibiotics in the Critically Ill Using Biosensors
Antibiotics · 22.09.2023 · 12 (10) · 1478
DOI: 10.3390/antibiotics12101478 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Antibiotics, online erschienen am 22.09.2023. Verfasst von Ruvimbo Dephine Mishi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Human Biology, Division of Cell Biology, University of Cape Town, Cape Town 7925, South Africa. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
By ensuring optimal dosing, therapeutic drug monitoring (TDM) improves outcomes in critically ill patients by maximizing effectiveness while minimizing toxicity. Current methods for measuring plasma drug concentrations, however, can be challenging, time-consuming, and slow to return an answer, limiting the extent to which TDM is used to optimize drug exposure. A potentially promising solution to this dilemma is provided by biosensors, molecular sensing devices that employ biorecognition elements to recognize and quantify their target molecules rapidly and in a single step. This paper reviews the current state of the art for biosensors regarding their application to TDM of antibiotics in the critically ill, both as ex vivo point-of-care devices supporting single timepoint measurements and in vivo devices supporting continuous real-time monitoring in situ in the body. This paper also discusses the clinical development of biosensors for TDM, including regulatory challenges and the need for standardized performance evaluation. We conclude by arguing that, through precise and real-time monitoring of antibiotics, the application of biosensors in TDM holds great promise for enhancing the optimization of drug exposure in critically ill patients, offering the potential for improved outcomes.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Human Biology, Division of Cell Biology, University of Cape Town, Cape Town 7925, South Africa.
- Paediatric Critical Care Unit, Department of Pharmacy, The Children's Hospital at Westmead, Sydney, NSW 2031, Australia.
- NSW Health Pathology, Department of Chemical Pathology, Prince of Wales Hospital, Sydney, NSW 2031, Australia.
- Department of Chemistry and Biochemistry, University of California Santa Barbara, Santa Barbara, CA 93106, USA.
- Center for Bioengineering, University of California Santa Barbara, Santa Barbara, CA 93106, USA.
- Biomolecular Sciences and Engineering, University of California, Santa Barbara, CA 93106, USA.
ORCID-Profile: Ruvimbo Dephine Mishi, Michael Andrew Stokes, Craig Anthony Campbell, Kevin William Plaxco, Sophie Lena Stocker
Zitieren
APA
Mishi, R. D., Stokes, M. A., Campbell, C. A., Plaxco, K. W., & Stocker, S. L. (2023). Real-Time Monitoring of Antibiotics in the Critically Ill Using Biosensors. Antibiotics, 12(10), 1478. https://doi.org/10.3390/antibiotics12101478
Vancouver
Mishi RD, Stokes MA, Campbell CA, Plaxco KW, Stocker SL. Real-Time Monitoring of Antibiotics in the Critically Ill Using Biosensors. Antibiotics. 2023;12(10):1478. doi:10.3390/antibiotics12101478
BibTeX
@article{Mishi2023,
author = {Mishi, Ruvimbo Dephine and Stokes, Michael Andrew and Campbell, Craig Anthony and Plaxco, Kevin William and Stocker, Sophie Lena},
title = {Real-Time Monitoring of Antibiotics in the Critically Ill Using Biosensors},
journal = {Antibiotics},
year = {2023},
volume = {12},
number = {10},
pages = {1478},
doi = {10.3390/antibiotics12101478}
}
EUVIMED